Abstract
MicroRNAs (miRNAs) are 18–22-nt noncoding RNAs that are involved in post-transcriptional regulation of genes. Oncomirs, a subclass of miRNAs, include genes whose expression, or lack thereof, are associated with cancers. Until the last decade, the domestic dog was an underused model for the study of various human diseases that have genetic components. The dog exhibits marked genetic and physiologic similarity to the human, thereby making it an excellent model for study and treatment of various hereditary diseases. Furthermore, because the dog presents with distinct, spontaneously occurring mammary tumors, it may serve as a model for genetic analysis and treatments of humans with malignant breast tumors. Because miRNAs have been found to act as both tumor suppressors and oncogenes in several different cancers, expression patterns of ten miRNAs (miR-15a, miR-16, miR-17-5p, miR-21, miR-29b, miR-125b, miR-145, miR-155, miR-181b, let-7f) known to be associated with human breast cancers were compared to malignant canine mammary tumors (n = 6) and normal canine mammary tissue (n = 10). Resulting data revealed miR-29b and miR-21 to have a statistically significant (p < 0.05 by MANOVA analysis) upregulation in cancerous samples. The ten canine miRNAs follow the same pattern of expression as in the human, except for miR-145 which does not show a difference in expression between the normal and cancerous canine samples. In addition, when analyzed according to specific cancer phenotypes, miR-15a and miR-16 show a significant downregulation in canine ductal carcinomas while miRsR-181b, -21, -29b, and let-7f show a significant upregulation in canine tubular papillary carcinomas.
Similar content being viewed by others
References
Ambros V (2004) The function of animal microRNAs. Nature 431:350–355
American Cancer Society (2007) Cancer facts and figures 2007. ACS, Atlanta, GA
Bandres E, Cubedo E, Agirre X, Malumbres R, Zarate R et al (2006) Identification by real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues. Mol Cancer 5:29
Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281–297
Berezikov E, Guryev V, van de Belt J, Wienholds E, Plasterk RHA et al (2005) Phylogenetic shadowing and computational identification of human microRNA genes. Cell 120:21–24
Blenkiron C, Goldstein LD, Thorne NP, Spiteri I, Chin SF et al (2007) MicroRNA expression profiling of human breast cancer identifies new markers of tumour subtype. Genome Biol 8:R214
Boggs RM, Moody JA, Long CR, Tsai KL, Murphy KE (2007) Identification, amplification and characterization of miR-17–92 from canine tissue. Gene 404:25–30
Bottoni A, Piccin D, Tagliati F, Luchin A, Zatelli MC et al (2005) miR-15a and miR-16-1 down-regulation in pituitary adenomas. J Cell Physiol 204:280–285
Bottoni A, Zatelli MC, Ferracin M, Tagliati F, Piccin D et al (2007) Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 210:370–377
Calin GA, Croce CM (2006) MicroRNA-cancer connection: the beginning of a new tale. Cancer Res 66:7390–7394
Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N et al (2004a) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci USA 101:11755–11760
Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E et al (2004b) Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101:2999–3004
Chen CZ, Lodish HF (2005) MicroRNAs as regulators of mammalian hematopoiesis. Semin Immunol 17:155–165
Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG et al (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334:1351–1358
Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102:13944–13949
Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S et al (2006) Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci USA 103:7024–7029
de las Mulas JM, Reymundo C, de los Monteros AE (2004) Calponin expression and myoepithelial cell differentiation in canine, feline and human mammary simple carcinomas. Vet Compar Oncol 2:24–35
Dickson RB, Pestell RG, Lippman ME (2005) Cancer of the breast. In: DeVita VT, Hellman S, Rosenberg S (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1399–1488
Dore M, Lanthier I, Sirois J (2003) Cyclooxygenase-2 expression in canine mammary tumors. Vet Pathol 40:207–212
Dorn CR, Taylor DO, Frye FL, Hibbard HH (1968) Survey of animal neoplasms in Alameda and Contra Costa Counties, California. I. Methodology and description of cases. J Natl Cancer Inst 40:295–305
Esquela-Kerscher A, Slack FJ (2006) Oncomirs—microRNAs with a role in cancer. Nat Rev Cancer 6:259–269
Fabbri M, Garzon R, Cimmino A, Liu Z, Zanesi N et al (2007) MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci USA 104:15805–15810
Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A et al (2007) Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026–1033
Griffiths-Jones S, Grocock RJ, Dongen Sv, Bateman A, Enright AJ (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res 34:D140–D144
He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D et al (2005) A microRNA polycistron as a potential human oncogene. Nature 435:828–833
Hossain A, Kuo MT, Saunders GF (2006) Mir-17–5p regulates breast cancer cell proliferation by inhibiting translation of AIB1 mRNA. Mol Cell Biol 26:8191–8201
Hwang H-W, Mendell JT (2006) MicroRNAs in cell proliferation, cell death, and tumorgenesis. Br J Cancer 94:776–780
Illera JC, Perez-Alenza MD, Nieto A, Jimenez MA, Silvan G et al (2006) Steroids and receptors in canine mammary cancer. Steroids 71:541–548
Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R et al (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65:7065–7070
Jiang J, Lee EJ, Gusev Y, Schmittgen TD (2005) Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucleic Acids Res 33:5394–5403
Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67:7713–7722
Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R et al (2005) RAS is regulated by the let-7 microRNA family. Cell 120:635–647
Kiriakidou M, Nelson PT, Kouranov A, Fitziev P, Bouyioukos C et al (2004) A combined computational-experimental approach predicts human microRNA targets. Genes Dev 18:1165–1178
Kirkness EF, Bafna V, Halpern AL, Levy S, Remington K et al (2003) The dog genome: survey sequencing and comparative analysis. Science 301:1898–1903
Kumaraguruparan R, Prathiba D, Nagini S (2006) Of humans and canines: immunohistochemical analysis of PCNA, Bcl-2, p53, cytokeratin and ER in mammary tumours. Res Vet Sci 81:218–224
Lana SE, Rutteman GR, Withrow SJ (2007) Tumors of the mammary gland. In: Withrow SJ, Vail DM (eds) Withrow & MacEwen’s small animal clinical oncology. Saunders Elsevier, St. Louis, pp 619–636
Lee YS, Kim HK, Chung S, Kim KS, Dutta A (2005) Depletion of human micro-RNA miR-125b reveals that it is critical for the proliferation of differentiated cells but not for the down-regulation of putative targets during differentiation. J Biol Chem 280:16635–16641
Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15–20
Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J et al (2005) MicroRNA expression profiles classify human cancers. Nature 435:834–838
Mattie MD, Benz CC, Bowers J, Sensinger K, Wong L et al (2006) Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies. Mol Cancer 5:24
Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST et al (2007) MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 133:647–658
Michael MZ, O’Connor SM, van Holst Pellekaan NG, Young GP, James RJ (2003) Reduced accumulation of specific microRNAs in colorectal neoplasia. Mol Cancer Res 1:882–891
Millanta F, Calandrella M, Bari G, Niccolini M, Vannozzi I et al (2005) Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues. Res Vet Sci 79:225–232
Mott JL, Kobayashi S, Bronk SF, Gores GJ (2007) mir-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 26:6133–6140
Mottolese M, Morelli L, Agrimi U, Benevolo M, Sciarretta F et al (1994) Spontaneous canine mammary tumors. A model for monoclonal antibody diagnosis and treatment of human breast cancer. Lab Invest 71:182–187
Nieto A, Pena L, Perez-Alenza MD, Sanchez MA, Flores JM et al (2000) Immunohistologic detection of estrogen receptor alpha in canine mammary tumors: clinical and pathologic associations and prognostic significance. Vet Pathol 37:239–247
Nieto A, Perez-Alenza MD, Del Castillo N, Tabanera E, Castano M et al (2003) BRCA1 expression in canine mammary dysplasias and tumours: relationship with prognostic variables. J Comp Pathol 128:260–268
O’Donnell KA, Wentzel EA, Zeller KI, Dang CV, Mendell JT (2005) c-Myc-regulated microRNAs modulate E2F1 expression. Nature 435:839–843
Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI et al (2000) Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86–89
Pekarsky Y, Santanam U, Cimmino A, Palamarchuk A, Efanov A et al (2006) Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 66:11590–11593
Philibert JC, Snyder PW, Glickman N, Glickman LT, Knapp DW et al (2003) Influence of host factors on survival in dogs with malignant mammary gland tumors. J Vet Intern Med 17:102–106
Roldo C, Missiaglia E, Hagan JP, Falconi M, Capelli P et al (2006) MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 24:4677–4684
Schneider R, Dorn CR, Taylor DO (1969) Factors influencing canine mammary cancer development and postsurgical survival. J Natl Cancer Inst 43:1249–1261
Si ML, Zhu S, Wu H, Lu Z, Wu F et al (2007) miR-21-mediated tumor growth. Oncogene 26:2799–2803
Silveri L, Tilly G, Vilotte JL, Le Provost F (2006) MicroRNA involvement in mammary gland development and breast cancer. Reprod Nutr Dev 46:549–556
Simon D, Schoenrock D, Baumgartner W, Nolte I (2006) Postoperative adjuvant treatment of invasive malignant mammary gland tumors in dogs with doxorubicin and docetaxel. J Vet Intern Med 20:1184–1190
Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A et al (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA 103:2257–2261
Wijnhoven BP, Michael MZ, Watson DI (2007) MicroRNAs and cancer. Br J Surg 94:23–30
Wu L, Belasco JG (2005) Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol Cell Biol 25:9198–9208
Zhang B, Pan X, Cobb GP, Anderson TA (2007) microRNAs as oncogenes and tumor suppressors. Dev Biol 302:1–12
Zhang L, Huang J, Yang N, Greshock J, Megraw MS et al (2006) microRNAs exhibit high frequency genomic alterations in human cancer. Proc Natl Acad Sci USA 103:9136–9141
Zhu S, Si ML, Wu H, Mo YY (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282:14328–14336
Acknowledgments
The authors thank the TAMU Statistics help desk for their aide and direction in the analysis portion of this project. Special thanks to Dr. Roy Pool for his help and interpretation of the biopsy reports used in this study.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Boggs, R.M., Wright, Z.M., Stickney, M.J. et al. MicroRNA expression in canine mammary cancer. Mamm Genome 19, 561–569 (2008). https://doi.org/10.1007/s00335-008-9128-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00335-008-9128-7